BREAST CANCER PATIENTS WANTED

(click here for downloadable PDF)

Looking for Breast Cancer patients who have been diagnosed with DCIS HER-2/neu, for Clinical Trial Vaccine at
the University of Pennsylvania.

If you have been diagnosed, make sure to find out if you are HER-2 - request this additional test from your doctor!

Results so far are extremely encouraging – to date, every patient has shown an immunological response to the vaccine. Additional patients are still needed to prove the trial. Clinical trials need both funding and participants to prove the research. Without one or the other, a trial cannot be completed, and the research must be abandoned. WE CANNOT ALLOW THAT TO HAPPEN. We are helping with the funding, but we need everyone's help to find enough patients for the trial!

A STEP AHEAD
For Penn Surgery, this evolving research may be its most promising discovery yet.
It is NOT a drug - it uses your own immune response to fight and prevent breast cancer.
It WILL be both a treatment, and a prevention for DCIS, an early form of breast cancer.
This treatment will be developed for invasive breast cancer as well!  
Your doctor will stay actively involved throughout your trial participation.

To find out if you qualify for the trial, please contact Jeanne Schueller at jeanne.schueller@uphs.upenn.edu.
RE: Dr. Czerniecki breast cancer vaccine trial. You can also reach Jeanne by phone at 215-349-8399, or by fax at 215-662-3179.

Trial expenses are covered by the research funding.

If you are not DCIS HER-2/neu, there are other trials in need of patients. PLEASE have your doctor go through the list at the National Cancer Institute (a part of the National Institutes of Health – NIH) to see if you qualify. Become an Unsung Hero of breast cancer!

For further information on this research trial, please go to our LINKS page on PenniesinAction.org. There is a description of Phase 2 of the trial, an article on the research from the PENN Medicine 2009 Annual Surgery Report , and links to other articles of interest as well as information on Dr. Czerniecki and his research.